Remote Strategic Account Liaison - Rare Neurology (ALS)

Otsuka America Pharmaceutical Inc.; Lansing (MI); Remote; USD 158,000 - 252,000; Full time

Benefits offered by this job

Medical benefits

401(k) match

Paid holidays

Paid time off

Job summary

Otsuka America Pharmaceutical, Inc. seeks a Strategic Account Liaison to support the launch and growth of its rare neurology portfolio, including FUS-ALS.

The role requires translating complex clinical data for ALS Centers of Excellence, providers, and stakeholders, and coordinating access and patient support programs through cross-functional teams. The SAL will drive regional strategy, navigate Payer and site-of-care dynamics, and align with Market Access to reduce barriers to therapy for

Qualifications

• Bachelor’s Degree required, US residency preferred.
• 10+ years of biotech/pharma commercial field experience (8+ considered).
• Experience with new product launches and market access.
• Familiarity with ALS, CNS, or rare neurology is a plus.
• Valid U.S. driver’s license and driving record compliance.

Responsibilities

• Communicate complex clinical data and treatment pathways to clinicians and stakeholders.
• Develop and maintain relationships with ALS Centers of Excellence and KOLs.
• Navigate hospital purchasing, coding, and reimbursement processes.
• Pull through access and patient support programs to enable therapy.
• Participate in conferences and medical meetings to educate on rare neurology.

Skills

Clinical acumen

HCP engagement

Strategic account planning

Cross-functional collaboration

Communication of data

Education

Bachelor's Degree

Biotech/Pharma commercial experience

Job description

Otsuka America Pharmaceutical, Inc. seeks a Strategic Account Liaison to support the launch and growth of its rare neurology portfolio, including FUS-ALS.

The role requires translating complex clinical data for ALS Centers of Excellence, providers, and stakeholders, and coordinating access and patient support programs through cross-functional teams. The SAL will drive regional strategy, navigate Payer and site-of-care dynamics, and align with Market Access to reduce barriers to therapy for